Search alternatives:
significant gender » significant concern (Expand Search), significant burden (Expand Search)
gender decrease » greater decrease (Expand Search), teer decrease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
significant gender » significant concern (Expand Search), significant burden (Expand Search)
gender decrease » greater decrease (Expand Search), teer decrease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
Mean scores, standard deviations, and significance on key measures and subscales by gender group.
Published 2025Subjects: -
2
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
10
-
11
-
12
-
13
The demographics questionnaire includes questions about age, education, gender and employment.
Published 2024Subjects: -
14
-
15
-
16
Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023.
Published 2025Subjects: -
17
Summary of effects of gender on RT (in ms, bars) and ACC (in %, line), with 95% confidence interval.
Published 2024Subjects: -
18
-
19
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”
-
20